Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Dexatrim, pHisoderm, Icy Hot Extensions Shipping In Coming Months

This article was originally published in The Tan Sheet

Executive Summary

Chattem is gearing up to launch a slew of product line extensions in the next few months as its decision to increase its investment in R&D over the past two years begins to pay dividends

You may also be interested in...



Chattem R&D

Mid-November completion of firm's $2 mil., 10,000 sq. ft. R&D facility in Chattanooga, Tenn. was about three weeks ahead of schedule, Chattem says (1"The Tan Sheet" Jan. 20, 2003, In Brief). In line with increased R&D efforts over the past two years, the firm is set to launch BullFrog Mosquito Coast, which combines sun screen with insect repellent and is designed to last six to eight hours (2"The Tan Sheet" Sept. 22, 2003, p. 4)...

Chattem R&D

Mid-November completion of firm's $2 mil., 10,000 sq. ft. R&D facility in Chattanooga, Tenn. was about three weeks ahead of schedule, Chattem says (1"The Tan Sheet" Jan. 20, 2003, In Brief). In line with increased R&D efforts over the past two years, the firm is set to launch BullFrog Mosquito Coast, which combines sun screen with insect repellent and is designed to last six to eight hours (2"The Tan Sheet" Sept. 22, 2003, p. 4)...

Pfizer BenGay Extension Challenges P&G In Topical Pain Patch Arena

A man strips off breakaway pants on a fashion runway to reveal Pfizer's new BenGay Pain Relieving Patch in national television spots, which broke Oct. 20

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel